IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $297,802 | -28.4% | 65,451 | +10.8% | 0.00% | 0.0% |
Q2 2023 | $415,789 | +40.9% | 59,061 | +22.3% | 0.00% | 0.0% |
Q1 2023 | $295,180 | -4.4% | 48,311 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $308,707 | -40.5% | 48,311 | -10.8% | 0.00% | 0.0% |
Q3 2022 | $519,000 | -13.2% | 54,131 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $598,000 | -82.9% | 54,131 | -74.2% | 0.00% | -85.7% |
Q1 2022 | $3,490,000 | -12.7% | 209,602 | +0.1% | 0.01% | 0.0% |
Q4 2021 | $3,998,000 | -22.5% | 209,449 | +0.2% | 0.01% | -30.0% |
Q3 2021 | $5,157,000 | -7.6% | 209,128 | -2.5% | 0.01% | -9.1% |
Q2 2021 | $5,582,000 | +7.4% | 214,526 | +30.7% | 0.01% | +10.0% |
Q1 2021 | $5,197,000 | -32.8% | 164,138 | -1.5% | 0.01% | -37.5% |
Q4 2020 | $7,731,000 | +41.6% | 166,618 | +0.5% | 0.02% | +33.3% |
Q3 2020 | $5,458,000 | +21.2% | 165,805 | +1.1% | 0.01% | +9.1% |
Q2 2020 | $4,503,000 | +206.5% | 164,035 | +234.3% | 0.01% | +175.0% |
Q1 2020 | $1,469,000 | +29.5% | 49,072 | +19.7% | 0.00% | +33.3% |
Q4 2019 | $1,134,000 | +62.7% | 40,982 | +7.0% | 0.00% | +50.0% |
Q3 2019 | $697,000 | -25.8% | 38,312 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $939,000 | +205.9% | 38,312 | +18.8% | 0.00% | +100.0% |
Q1 2019 | $307,000 | +7.3% | 32,262 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $286,000 | -11.2% | 32,262 | +12.8% | 0.00% | 0.0% |
Q3 2018 | $322,000 | +8.1% | 28,612 | +22.8% | 0.00% | 0.0% |
Q2 2018 | $298,000 | +20.6% | 23,292 | +59.2% | 0.00% | 0.0% |
Q1 2018 | $247,000 | – | 14,632 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |